BackgroundHigh-throughput technologies, such as DNA microarray, have significantly advanced biological and biomedical research by enabling researchers to carry out genome-wide screens. One critical task in analyzing genome-wide datasets is to control the false discovery rate (FDR) so that the proportion of false positive features among those called significant is restrained. Recently a number of FDR control methods have been proposed and widely practiced, such as the Benjamini-Hochberg approach, the Storey approach and Significant Analysis of Microarrays (SAM).MethodsThis paper presents a straight-forward yet powerful FDR control method termed miFDR, which aims to minimize FDR when calling a fixed number of significant features. We theoretically proved that the strategy used by miFDR is able to find the optimal number of significant features when the desired FDR is fixed.ResultsWe compared miFDR with the BH approach, the Storey approach and SAM on both simulated datasets and public DNA microarray datasets. The results demonstrated that miFDR outperforms others by identifying more significant features under the same FDR cut-offs. Literature search showed that many genes called only by miFDR are indeed relevant to the underlying biology of interest.ConclusionsFDR has been widely applied to analyzing high-throughput datasets allowed for rapid discoveries. Under the same FDR threshold, miFDR is capable to identify more significant features than its competitors at a compatible level of complexity. Therefore, it can potentially generate great impacts on biological and biomedical research.AvailabilityIf interested, please contact the authors for getting miFDR.
BackgroundPerforming statistical tests is an important step in analyzing genome-wide datasets for detecting genomic features differentially expressed between conditions. Each type of statistical test has its own advantages in characterizing certain aspects of differences between population means and often assumes a relatively simple data distribution (e.g., Gaussian, Poisson, negative binomial, etc.), which may not be well met by the datasets of interest. Making insufficient distributional assumptions can lead to inferior results when dealing with complex differential expression patterns.ResultsWe propose to capture differential expression information more comprehensively by integrating multiple test statistics, each of which has relatively limited capacity to summarize the observed differential expression information. This work addresses a general application scenario, in which users want to detect as many as DEFs while requiring the false discovery rate (FDR) to be lower than a cut-off. We treat each test statistic as a basic attribute, and model the detection of differentially expressed genomic features as learning a discriminant boundary in a multi-dimensional space of basic attributes. We mathematically formulated our goal as a constrained optimization problem aiming to maximize discoveries satisfying a user-defined FDR. An effective algorithm, Discriminant-Cut, has been developed to solve an instantiation of this problem. Extensive comparisons of Discriminant-Cut with 13 existing methods were carried out to demonstrate its robustness and effectiveness.ConclusionsWe have developed a novel machine learning methodology for robust differential expression analysis, which can be a new avenue to significantly advance research on large-scale differential expression analysis.Electronic supplementary materialThe online version of this article (doi:10.1186/s12859-016-1386-x) contains supplementary material, which is available to authorized users.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.